MC4R Variant (rs17782313)

Your MC4R variant result (rs17782313, near the melanocortin 4 receptor gene) tells you something simple but important: how much your DNA nudges your body toward gaining weight. Everyone's weight is shaped by hundreds of genetic influences layered on top of diet, exercise, sleep, and stress. This particular variant is one of the most well-studied genetic contributors to obesity risk, and knowing your result can help you understand whether your body faces a steeper uphill climb when it comes to maintaining a healthy weight.

The test looks at a single spot in your DNA near the MC4R (melanocortin 4 receptor) gene, where you can carry either a T or a C version (called alleles). You inherit one copy from each parent, so your result will be one of three genotypes: T/T, T/C, or C/C. Each copy of the C allele incrementally increases your risk of obesity, following what geneticists call an additive model: more C alleles, more risk.

What Your Genotype Means

The MC4R gene encodes a receptor in your brain that helps regulate appetite and energy balance. Think of it as a thermostat for hunger. The rs17782313 variant sits near this gene and influences how it works. The C allele is common, carried by roughly 23-27% of people in most populations, so having one or even two copies is not unusual.

Your weight-related risk scales with the number of C alleles you carry. If you are T/T, you are at the baseline. If you are T/C, each C allele adds roughly 0.20-0.25 kg/m² to BMI, about 0.5-0.7 cm to waist circumference, and approximately 0.7-1.0 kg to body weight. If you are C/C, those effects roughly double.

Sources: Yu et al. (2020); Cheraghi et al. (2025); Zobel et al. (2009)

What this means for you: if you carry one or two C alleles and have struggled with your weight, this result confirms that part of that struggle has a real biological basis. But "higher genetic risk" does not mean destiny. This variant is one of many genetic factors influencing weight, and environmental factors, lifestyle, and other genes collectively have much larger effects than this single variant alone.

The C allele is also associated with slightly higher blood glucose levels, independent of its effects on weight. So even if your BMI is in a healthy range, it may be worth keeping an eye on your metabolic markers.

How This Variant Differs from Rare MC4R Mutations

It is worth understanding what this test does not tell you. The rs17782313 variant is a common polymorphism found in a large share of the population. It is not the same as the rare coding mutations in the MC4R gene that cause severe, early-onset obesity. Those rare mutations directly break or impair the MC4R receptor itself and affect roughly 2-5% of people with severe obesity. The common variant tested here contributes a small, incremental push toward weight gain, not a dramatic disruption of appetite signaling.

What You Can Do About Your Result

You cannot change your genotype, but you can change how much it matters. Several lines of evidence suggest that lifestyle choices can blunt or even neutralize the obesity risk this variant confers.

Physical activity: In a study of over 25,000 adults, the link between rs17782313 and higher BMI was only detectable in sedentary people. Among physically active individuals, the genetic effect was eliminated entirely. This interaction was especially strong in younger adults aged 20-40. If you carry the C allele, regular exercise may be one of the most powerful tools you have to counteract your genetic predisposition.

Diet quality: In a study examining Mediterranean diet patterns, people who carried multiple obesity risk alleles (including MC4R variants) but maintained high adherence to a Mediterranean diet had BMI levels similar to those with no risk alleles at all. The combination of vegetables, fruits, whole grains, legumes, fish, and olive oil appeared to offset genetic risk.

Structured lifestyle programs: Results from formal weight-loss interventions are mixed. In the Diabetes Prevention Program, some MC4R variants were associated with greater weight reduction in the lifestyle intervention group compared to controls. Among women with prior gestational diabetes, those carrying MC4R risk alleles (CC or TC genotypes) actually showed better improvement in insulin resistance with lifestyle intervention than those with the TT genotype. However, other studies found no difference in weight loss by genotype during lifestyle programs, in both adults and children.

GLP-1 receptor agonist medications: These newer weight-loss drugs, including liraglutide and semaglutide, work through a pathway that is independent of the MC4R receptor. In a clinical study, liraglutide 3.0 mg produced similar weight loss in people with MC4R mutations (6.8 kg) and matched controls without mutations (6.1 kg) over 16 weeks, representing about 6% of total body weight in both groups. Preclinical data from 2026 further confirms that semaglutide, tirzepatide, and retatrutide all produce substantial weight reduction in models with completely nonfunctional MC4R, along with improvements in insulin resistance, cholesterol, and liver markers. If you carry this variant and are considering medication for weight management, GLP-1 receptor agonists remain a strong option.

Bariatric surgery: For the common rs17782313 variant specifically, the evidence suggests no significant impact on surgical weight-loss outcomes. The picture is more nuanced for people with rare pathogenic MC4R mutations (a different situation from the common variant): one multicenter study found inferior weight loss after sleeve gastrectomy in those with rare mutations (22.6% total weight loss at one year vs. 29.9% in controls), while Roux-en-Y gastric bypass produced comparable initial results. But for typical carriers of the rs17782313 C allele, surgery appears to work as expected.

Putting It in Perspective

This variant is one thread in a very large tapestry. Carrying the C allele does not determine your weight any more than carrying a gene for tallness guarantees you will play basketball. What it does is help explain part of the biological hand you were dealt. For people who have worked hard at weight management and felt the deck was stacked against them, this information can be validating. For everyone, it points toward the same actionable conclusion: staying physically active and eating well are not just generically good advice; they are strategies with demonstrated ability to offset this specific genetic risk.

Questions This Biomarker Can Answer

• Is my difficulty maintaining a healthy weight partly genetic?
• Does my DNA place me at higher risk for obesity compared to the general population?
• Am I likely to benefit from extra emphasis on physical activity to manage my weight?
• Will GLP-1 receptor agonist medications like semaglutide work for me despite carrying an obesity risk variant?
• Is my genetic profile associated with slightly elevated blood glucose, independent of my weight?